Streamline Health Valuation
| STRM Stock | USD 0.34 0.01 3.03% |
Streamline Health seems to be undervalued based on Macroaxis valuation methodology. Our model measures the value of Streamline Health from inspecting the company fundamentals such as Return On Equity of -0.72, operating margin of (0.71) %, and Shares Outstanding of 59.09 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Streamline Health's valuation include:
Price Book 0.9873 | Enterprise Value -1.9 M | Enterprise Value Ebitda (1.88) | Price Sales 0.8132 | Enterprise Value Revenue 1.1149 |
Undervalued
Today
Please note that Streamline Health's price fluctuation is out of control at this time. Calculation of the real value of Streamline Health is based on 3 months time horizon. Increasing Streamline Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Streamline Health Solutions is useful when determining the fair value of the Streamline stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Streamline Health. Since Streamline Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Streamline Stock. However, Streamline Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.34 | Real 0.56 | Target 1.25 | Hype 0.34 | Naive 0.34 |
The real value of Streamline Stock, also known as its intrinsic value, is the underlying worth of Streamline Health Company, which is reflected in its stock price. It is based on Streamline Health's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Streamline Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Streamline Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Streamline Health Solutions helps investors to forecast how Streamline stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Streamline Health more accurately as focusing exclusively on Streamline Health's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Streamline Health's intrinsic value based on its ongoing forecasts of Streamline Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Streamline Health's closest peers. When choosing an evaluation method for Streamline Health, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Streamline Health Investments |
|
Streamline Valuation Trend
Knowing Streamline Health's actual value is paramount for traders to make sound investment determinations. Streamline Health's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Streamline Health's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Streamline Health's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Streamline Market Cap
Streamline Health Solutions is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 10.3 Billion. Streamline Health adds roughly 19.56 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Streamline Health Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Streamline Health's current stock value. Our valuation model uses many indicators to compare Streamline Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Streamline Health competition to find correlations between indicators driving Streamline Health's intrinsic value. More Info.Streamline Health Solutions is rated second in price to earning category among related companies. It is rated below average in price to book category among related companies . The ratio of Price To Earning to Price To Book for Streamline Health Solutions is about 325.81 . As of the 25th of April 2024, Price To Book Ratio is likely to drop to 3.28. Comparative valuation analysis is a catch-all model that can be used if you cannot value Streamline Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Streamline Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Streamline Health's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Streamline Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Streamline Health and how it compares across the competition.
About Streamline Health Valuation
The stock valuation mechanism determines the current worth of Streamline Health Solutions on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Streamline Health Solutions. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Streamline Health based exclusively on its fundamental and basic technical indicators. By analyzing Streamline Health's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Streamline Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Streamline Health. We calculate exposure to Streamline Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Streamline Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 13.2 M | 9.8 M | |
| Pretax Profit Margin | (0.41) | (0.39) | |
| Operating Profit Margin | (0.39) | (0.37) | |
| Net Loss | (0.41) | (0.39) | |
| Gross Profit Margin | 0.42 | 0.40 |
8 Steps to conduct Streamline Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Streamline Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Streamline Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Streamline Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Streamline Health's revenue streams: Identify Streamline Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Streamline Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Streamline Health's growth potential: Evaluate Streamline Health's management, business model, and growth potential.
- Determine Streamline Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Streamline Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Streamline Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Streamline Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 49.3 M | |
| Quarterly Earnings Growth Y O Y | 12.131 |
Streamline Health Current Valuation Indicators
Valuation refers to the process of determining the present value of Streamline Health Solutions and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Streamline we look at many different elements of the entity such as Streamline's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Streamline Health's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Streamline Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Streamline Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Streamline Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Streamline Health's worth.When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.35) | Revenue Per Share 0.428 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.